Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-090667
Filing Date
2016-01-11
Accepted
2016-01-11 09:12:50
Documents
1
Period of Report
2016-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4120
  Complete submission text file 0001209191-16-090667.txt   5585
Mailing Address C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address
Tepper Mark (Reporting) CIK: 0001291087 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37348 | Film No.: 161335269

Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations